BioSpace News Archive

Business

Amedisys Names Nick Muscato as Chief Strategy Officer

Amedisys, Inc., a leading provider of home health, hospice, personal care and high-acuity care, announces the promotion of Nick Muscato to Chief Strategy Officer, effective immediately.

April 26, 2022
·
4 min read
Biotech Beach

Halozyme Commences Tender Offer For All Outstanding Shares Of Common Stock Of Antares Pharma

Halozyme Therapeutics, Inc. announced that it is commencing, through a wholly owned subsidiary, Atlas Merger Sub, Inc., a cash tender offer to purchase all outstanding shares of common stock of Antares Pharma, Inc. for $5.60 per share in cash.

April 26, 2022
·
10 min read
Business

Blueprint Medicines to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022

Blueprint Medicines Corporation today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, May 3, 2022 to report its first quarter 2022 financial results and provide a corporate update.

April 26, 2022
·
1 min read
Business

INOVIO to Report First Quarter 2022 Financial Results on May 10, 2022

INOVIO (NASDAQ: INO) announced today that first quarter 2022 financial results will be released after the market close on May 10, 2022.

April 26, 2022
·
4 min read
Pharm Country

Iveric Bio to Participate in the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference

IVERIC bio, Inc. announced that Pravin U. Dugel, M.D., President, will participate in a fireside chat at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference on Thursday, April 28, 2022, at 9:00 a.m. Eastern Time.

April 26, 2022
·
2 min read
Business

Adaptive Phage Therapeutics Appoints Rob Casper as Vice President of Clinical Operations

Adaptive Phage Therapeutics, Inc. today announced the appointment of Rob Casper as Vice President of Clinical Operations.

April 26, 2022
·
3 min read
Business

Flare Therapeutics Appoints Adrian Jubb as Chief Medical Officer

Flare Therapeutics today announced the appointment of Adrian Jubb, MB ChB, PhD, FRCPath, as Chief Medical Officer.

April 26, 2022
·
3 min read
Business

Lineage to Present at B. Riley Securities 2022 Neuro & Ophthalmology Virtual Investor Conference on April 27, 2022

Lineage Cell Therapeutics, Inc. announced today Brian M. Culley, Lineage’s Chief Executive Officer, will present at the B. Riley Securities 2022 Neuro & Ophthalmology Virtual Investor Conference.

April 26, 2022
·
2 min read
Pharm Country

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

Protagenic Therapeutics, Inc. a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, announced will be presenting at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference tomorrow, April 27, 2022.

April 26, 2022
·
2 min read
Biotech Beach

Establishment Labs Enters Into $225 Million Credit Facility With Oaktree

Establishment Labs Holdings Inc. today announced that it has entered into a $225 million term loan financing facility with funds managed by Oaktree Capital Management, L.P. (“Oaktree”).

April 26, 2022
·
8 min read